## AMBA: Ambarella, Inc. - XLK: Technology

### Executive Summary

No thesis match: MRS_20 -3.3% below STRENGTH zone (4.0-10.0%); PEG 4.96 fails VALUE criteria (<1.0). Stock is in no-man's land without clear edge. Caution: declining volume (59% of avg).

- **Horizon:** N/A - no position
- **Risk Profile:** N/A - avoiding
- **Stop Type:** Fixed 2xATR ($69.82)
- **If Wrong:** N/A - wait for clearer setup
- **Invalidation:** MRS_20 falling below -5% or breaking key support

### News

- **Articles:** 2
- **Sentiment:** Bullish (Bullish: 0, Bearish: 0)

**1. Arrowstreet Capital Limited Partnership Purchases 101,389 Shares of Ambarella, Inc. $AMBA**
- Source: MarketBeat | 20251211T080956 | Somewhat-Bullish | Relevance: 97%
- Arrowstreet Capital Limited Partnership significantly increased its holdings in Ambarella, Inc. (NASDAQ:AMBA) by 899.6% in the second quarter, now owning 112,659 shares valued at $7.44 million. Other institutional investors also adjusted their positions, with overall institutional ownership at 82.09%. Insider transactions indicate some share sales, while analysts maintain a "Moderate Buy" rating with a consensus price target of $96.00 for Ambarella's stock.

**2. Navitas Semiconductor Soars 172% YTD: Is the Stock Still Worth Buying?**
- Source: Finviz | 20251209T170914 | Somewhat-Bullish | Relevance: 63%
-  Navitas Semiconductor (NVTS) shares have surged 172% year-to-date, fueled by its focus on power chips for AI data centers and a strategic shift to cost-efficient manufacturing. The company is actively repositioning itself into high-power markets like AI, energy storage, and grid infrastructure, including its integration into NVIDIAâ€™s new 800-volt AI factory ecosystem. Despite premium valuations, the long-term prospects are strong due to increasing demand for its GaN and SiC technologies in AI data centers.

### Analyst Activity

**Target Signal:** NEUTRAL (Raises: 3, Lowers: 0)

| Date | Firm | Target | Prior | Change |
|------|------|--------|-------|--------|
| 2025-11-26 | B of A Securiti | $92 | $90 | +2% |
| 2025-11-26 | Rosenblatt | $115 | $100 | +15% |
| 2025-11-26 | Stifel | $100 | $90 | +11% |
| 2025-11-26 | Needham | $100 | $100 | 0% |

**Rating Changes:**

| Date | Firm | Action | Grade |
|------|------|--------|-------|
| 2025-11-26 | B of A Securiti | main | Neutral |
| 2025-11-26 | Rosenblatt | main | Buy |
| 2025-11-26 | Stifel | reit | Buy |
| 2025-11-26 | Needham | reit | Buy |

### Insider Activity (90 days)

| Metric | Value |
|--------|-------|
| Direction | **NET_SELLING** |
| Buys | 0 ($0.00M) |
| Sells | 8 ($2.16M) |

### Institutional Ownership

| Metric | Value |
|--------|-------|
| Total Ownership | 40.6% |
| Smart Money | **BULLISH** |
| Net Flow | 0.0% |
| Buying/Selling | 8 / 2 |

**Top Holders:**
- Vanguard Group Inc: 12.0% (+0.1%)
- Blackrock Inc.: 9.1% (+0.1%)
- State Street Corpora: 3.9% (-9.4%)
- Jericho Capital Asse: 2.8% (+10.5%)
- Fuller & Thaler Asse: 2.6% (+8.9%)

### Key Risks

1. High beta (1.98) amplifies market volatility - any risk-off move could trigger sharp selloff.
2. Valuation stretched: PEG 5.0x requires aggressive growth execution.
3. Market regime shift could impact high-beta names disproportionately.

### Catalysts

- Analyst target momentum: 3 raises (avg +9%) could attract flows.
- Broader market risk-on sentiment could lift quality names.

### Fundamentals

PEG ratio 4.96 signals overvaluation risk, limited margin of safety. Forward P/E 128.0x stretched relative to 4% growth. Balance sheet: strong liquidity (2.7x), low leverage (D/E 0.27). Analyst sentiment positive (3 raises, avg +9%). Insider selling cluster ($2.2M in 90 days), potential headwind. Institutional flow bullish (8 buying vs 2 selling).

| Metric | Value |
|--------|-------|
| Market Cap | $3.4B |
| Beta | 1.98 |
| 52W Range | $38.86 - $96.69 |
| Short Interest | 7.7% |

| Valuation | Value |
|-----------|-------|
| PEG Ratio | 4.96 |
| Forward P/E | 128.0 |
| Current P/E | 133.5 |
| YoY Growth | 4.3% |
| EPS Direction | RISING |

### Technicals

MRS_20 strengthening from -12.8% to -3.3% (+9.5% in 5 days), confirming momentum buildup. Below STRENGTH zone by 7.3pp (needs >4.0% for momentum thesis). MRS_5 turning positive (2.2%) - potential reversal signal. Underperforming sector by 4.4pp, stock-specific weakness. Long-term uptrend intact (above SMA200 at 1.18x) but short-term weakness (below SMA20). RSI neutral at 48. Volume at 59% of 20MA suggests lack of conviction.

| Metric | Value | Signal |
|--------|-------|--------|
| MRS_20 | -3.30% (CS: 21) | Weak |
| RSI_14 | 48.4 | Neutral |
| MACD Histogram | 0.13 | Bullish |
| vs SMA20 | 0.989x | Below |
| vs SMA50 | 0.953x | Below |
| vs SMA200 | 1.179x | Above |

### Decision

- **Verdict:** AVOID
- **Thesis:** NEUTRAL

### Trade Setup

- **Entry:** $79.14
- **Stop Loss:** $69.82 (11.8% risk)
- **Target:** $88.46 (R:R method)
- **Risk/Reward:** 1.00:1
- **Target Reasoning:** NEUTRAL thesis targets 1.0x risk/reward based on historical edge

### Position Sizing

- **Shares:** 148
- **Position Value:** $11,712.72
- **Portfolio %:** 11.71%
- **Risk Dollars:** $1,380.00
- **Risk Per Trade:** 1.38%
- **Modifiers:** L1 115% | L2 120% | Combined 1.38x

### Market Context

| Layer | Signal | Modifier |
|-------|--------|----------|
| L1 Macro | NORMAL (MEDIUM) | 1.15x |
| L2 Sector | TREND (Zone A) | 1.20x |

*NORMAL regime with moderate risk appetite ahead of Fed decision. VIX at low 8th percentile signals complacency, but decent breadth and positive yield curve support selective positioning. Focus on quality names with earnings visibility.*

### Earnings

**Next:** 2026-02-25 (Est: $0.10)

| Quarter | Est | Actual | Surprise |
|---------|-----|--------|----------|
| 2025Q4 | $0.21 | $0.27 | +29.6% |
| 2025Q3 | $0.05 | $0.15 | +177.1% |
| 2025Q2 | $0.04 | $0.07 | +83.1% |
| 2025Q1 | $-0.02 | $0.11 | +651.4% |

---
*RULE-based L3 | 2026-01-06 16:36 | MRS_20*